Transcription of the gene encoding TNF-α is increased by IL-1β in rat and human islets and β-cell lines

Molecular Immunology

Volumn 62, Issue 1, 2014, Pages 54-62

  Burke, Susan J ^a   Lu, Danhong ^b   Sparer, Tim E ^c   Karlstad, Michael D ^d   Collier, J Jason ^a  

^a PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF TENNESSEE   (United States)

^d UNIVERSITY OF TENNESSEE MEDICAL CENTER   (United States)

Author keywords

Cytokine; Diabetes mellitus; Inflammation; Islet; NF B; Transcription

Indexed keywords

CD11B ANTIGEN; GLYCOPROTEIN P 15095; HISTONE H3; I KAPPA B KINASE BETA; INTERLEUKIN 1BETA; RNA POLYMERASE II; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA; I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DIABETES MELLITUS; DISEASE COURSE; GENE CONTROL; GENETIC TRANSCRIPTION; HISTONE METHYLATION; HUMAN; HUMAN CELL; INFLAMMATION; MOUSE; NEUTROPHIL; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RAT; UPREGULATION; ANIMAL; BAGG ALBINO MOUSE; CELL LINE; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; METABOLISM; SIGNAL TRANSDUCTION;

ANIMALS; CELL LINE; GENE EXPRESSION REGULATION; HUMANS; I-KAPPA B KINASE; INSULIN-SECRETING CELLS; INTERLEUKIN-1BETA; MICE; MICE, INBRED BALB C; NF-KAPPA B; RATS; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84902968614     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2014.05.019     Document Type: Article

References (60)

1. Croft M., Benedict C.A., Ware C.F. Clinical targeting of the TNF and TNFR superfamilies. Nat. Rev. Drug Discovery 2013, 12:147-168.
2. Hotamisligil G.S., Arner P., Caro J.F., Atkinson R.L., Spiegelman B.M. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J. Clin. Invest. 1995, 95:2409-2415.
3. Hotamisligil G.S., Shargill N.S., Spiegelman B.M. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 1993, 259:87-91.
4. Meldrum D.R. Tumor necrosis factor in the heart. Am. J. Physiol. 1998, 274:R577-R595.
5. Oral H., Kapadia S., Nakano M., Torre-Amione G., Lee J., Lee-Jackson D., Young J.B., Mann D.L. Tumor necrosis factor-alpha and the failing human heart. Clin. Cardiol. 1995, 18:IV20-IV27.
6. Balkwill F. Tumour necrosis factor and cancer. Nat. Rev. Cancer 2009, 9:361-371.
7. Carswell E.A., Old L.J., Kassel R.L., Green S., Fiore N., Williamson B. An endotoxin-induced serum factor that causes necrosis of tumors. Proc. Nat. Acad. Sci. U.S.A. 1975, 72:3666-3670.
8. Baud V., Karin M. Signal transduction by tumor necrosis factor and its relatives. Trends Cell Biol. 2001, 11:372-377.
9. Ben-Neriah Y., Karin M. Inflammation meets cancer, with NF-kappaB as the matchmaker. Nat. Immunol. 2011, 12:715-723.
10. Baker R.G., Hayden M.S., Ghosh S. NF-kappaB, inflammation, and metabolic disease. Cell Metab. 2011, 13:11-22.
11. Padgett L.E., Broniowska K.A., Hansen P.A., Corbett J.A., Tse H.M. The role of reactive oxygen species and proinflammatory cytokines in type 1 diabetes pathogenesis. Ann. N.Y. Acad. Sci. 2013, 1281:16-35. 10.1111/j.1749-6632.2012.06826.x.
12. Burke S.J., Updegraff B.L., Bellich R.M., Goff M.R., Lu D., Minkin S.C., Karlstad M.D., Collier J.J. Regulation of iNOS gene transcription by IL-1beta and IFN-gamma requires a coactivator exchange mechanism. Mol. Endocrinol. 2013, 27:1724-1742.
13. Corbett J.A., McDaniel M.L. Does nitric oxide mediate autoimmune destruction of beta-cells? Possible therapeutic interventions in IDDM. Diabetes 1992, 41:897-903.
14. Burke S.J., Lu D., Sparer T.E., Masi T., Goff M.R., Karlstad M.D., Collier J.J. NF-kappaB and STAT1 control CXCL1 and CXCL2 gene transcription. Am. J. Physiol.: Endocrinol. Metab. 2014, 306:E131-E149.
15. Cowley M.J., Weinberg A., Zammit N.W., Walters S.N., Hawthorne W.J., Loudovaris T., Thomas H., Kay T., Gunton J.E., Alexander S.I., Kaplan W., Chapman J., O'Connell P.J., Grey S.T. Human islets express a marked proinflammatory molecular signature prior to transplantation. Cell Transplant. 2012, 21:2063-2078.
16. Burke S.J., Goff M.R., Lu D., Proud D., Karlstad M.D., Collier J.J. Synergistic expression of the CXCL10 gene in response to IL-1beta and IFN-gamma involves NF-kappaB, phosphorylation of STAT1 at Tyr701, and acetylation of histones H3 and H4. J. Immunol. 2013, 191:323-336.
17. Burke S.J., Goff M.R., Updegraff B.L., Lu D., Brown P.L., Minkin S.C., Biggerstaff J.P., Zhao L., Karlstad M.D., Collier J.J. Regulation of the CCL2 gene in pancreatic beta-Cells by IL-1beta and glucocorticoids: role of MKP-1. PLoS One 2012, 7:e46986.
18. Rehman K.K., Bertera S., Bottino R., Balamurugan A.N., Mai J.C., Mi Z., Trucco M., Robbins P.D. Protection of islets by in situ peptide-mediated transduction of the Ikappa B kinase inhibitor Nemo-binding domain peptide. J. Biol. Chem. 2003, 278:9862-9868.
19. Giannoukakis N., Rudert W.A., Trucco M., Robbins P.D. Protection of human islets from the effects of interleukin-1beta by adenoviral gene transfer of an Ikappa B repressor. J. Biol. Chem. 2000, 275:36509-36513.
20. Collier J.J., Burke S.J., Eisenhauer M.E., Lu D., Sapp R.C., Frydman C.J., Campagna S.R. Pancreatic beta-cell death in response to pro-inflammatory cytokines is distinct from genuine apoptosis. PLoS One 2011, 6:e22485.
21. Collier J.J., Fueger P.T., Hohmeier H.E., Newgard C.B. Pro- and antiapoptotic proteins regulate apoptosis but do not protect against cytokine-mediated cytotoxicity in rat islets and beta-cell lines. Diabetes 2006, 55:1398-1406.
22. Steer S.A., Scarim A.L., Chambers K.T., Corbett J.A. Interleukin-1 stimulates beta-cell necrosis and release of the immunological adjuvant HMGB1. PLoS Med. 2006, 3:e17.
23. Lehuen A., Diana J., Zaccone P., Cooke A. Immune cell crosstalk in type 1 diabetes. Nat. Rev. Immunol. 2010, 10:501-513.
24. Masters S.L., Dunne A., Subramanian S.L., Hull R.L., Tannahill G.M., Sharp F.A., Becker C., Franchi L., Yoshihara E., Chen Z., Mullooly N., Mielke L.A., Harris J., Coll R.C., Mills K.H., Mok K.H., Newsholme P., Nunez G., Yodoi J., Kahn S.E., Lavelle E.C., O'Neill L.A. Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1beta in type 2 diabetes. Nat. Immunol. 2010, 11:897-904.
25. Dinarello C.A., Donath M.Y., Mandrup-Poulsen T. Role of IL-1beta in type 2 diabetes. Curr. Opin. Endocrinol., Diabetes Obes. 2010, 17:314-321.
26. Wilson C.A., Jacobs C., Baker P., Baskin D.G., Dower S., Lernmark A., Toivola B., Vertrees S., Wilson D. IL-1 beta modulation of spontaneous autoimmune diabetes and thyroiditis in the BB rat. J. Immunol. 1990, 144:3784-3788.
27. Ehses J.A., Lacraz G., Giroix M.H., Schmidlin F., Coulaud J., Kassis N., Irminger J.C., Kergoat M., Portha B., Homo-Delarche F., Donath M.Y. IL-1 antagonism reduces hyperglycemia and tissue inflammation in the type 2 diabetic GK rat. Proc. Nat. Acad. Sci. U.S.A. 2009, 106:13998-14003.
28. Jacob C.O., Aiso S., Michie S.A., McDevitt H.O., Acha-Orbea H. Prevention of diabetes in nonobese diabetic mice by tumor necrosis factor (TNF): similarities between TNF-alpha and interleukin 1. Proc. Nat. Acad. Sci. U.S.A. 1990, 87:968-972.
29. Grewal I.S., Grewal K.D., Wong F.S., Picarella D.E., Janeway C.A., Flavell R.A. Local expression of transgene encoded TNF alpha in islets prevents autoimmune diabetes in nonobese diabetic (NOD) mice by preventing the development of auto-reactive islet-specific T cells. J. Exp. Med. 1996, 184:1963-1974.
30. Yang X.D., Tisch R., Singer S.M., Cao Z.A., Liblau R.S., Schreiber R.D., McDevitt H.O. Effect of tumor necrosis factor alpha on insulin-dependent diabetes mellitus in NOD mice. I. The early development of autoimmunity and the diabetogenic process. J. Exp. Med. 1994, 180:995-1004.
31. Green E.A., Eynon E.E., Flavell R.A. Local expression of TNFalpha in neonatal NOD mice promotes diabetes by enhancing presentation of islet antigens. Immunity 1998, 9:733-743.
32. Larsen C.M., Faulenbach M., Vaag A., Ehses J.A., Donath M.Y., Mandrup-Poulsen T. Sustained effects of interleukin-1 receptor antagonist treatment in type 2 diabetes. Diabetes Care 2009, 32:1663-1668.
33. van Asseldonk E.J., Stienstra R., Koenen T.B., Joosten L.A., Netea M.G., Tack C.J. Treatment with Anakinra improves disposition index but not insulin sensitivity in nondiabetic subjects with the metabolic syndrome: a randomized, double-blind, placebo-controlled study. J. Clin. Endocrinol. Metab. 2011, 96:2119-2126.
34. Larsen C.M., Faulenbach M., Vaag A., Volund A., Ehses J.A., Seifert B., Mandrup-Poulsen T., Donath M.Y. Interleukin-1-receptor antagonist in type 2 diabetes mellitus. N. Engl. J. Med. 2007, 356:1517-1526.
35. + channel-dependent and -independent glucose-stimulated insulin secretion. Diabetes 2000, 49:424-430.
36. Herz J., Gerard R.D. Adenovirus-mediated transfer of low density lipoprotein receptor gene acutely accelerates cholesterol clearance in normal mice. Proc. Nat. Acad. Sci. U.S.A. 1993, 90:2812-2816.
37. Jobin C., Panja A., Hellerbrand C., Iimuro Y., Didonato J., Brenner D.A., Sartor R.B. Inhibition of proinflammatory molecule production by adenovirus-mediated expression of a nuclear factor kappaB super-repressor in human intestinal epithelial cells. J. Immunol. 1998, 160:410-418.
38. Burke S.J., Collier J.J. The gene encoding cyclooxygenase-2 is regulated by IL-1beta and prostaglandins in 832/13 rat insulinoma cells. Cell Immunol. 2011, 271:379-384.
39. Green E.A., Flavell R.A. Tumor necrosis factor-alpha and the progression of diabetes in non-obese diabetic mice. Immunol. Rev. 1999, 169:11-22.
40. el-Nawawy A., Soliman T., el-Azzouni O., Abbassy A.A., Massoud M.N., Marzouk S., Ibrahim F., Helal L. Interleukin-1-beta, tumor necrosis factor-alpha, insulin secretion and oral glucose tolerance in non-diabetic siblings of children with IDDM. Indian J. Pediatr. 1998, 65:455-460.
41. Lorini R., De Amici M., d'Annunzio G., Vitali L., Scaramuzza A. Low serum levels of tumor necrosis factor-alpha in insulin-dependent diabetic children. Horm. Res. 1995, 43:206-209.
42. Mokhtari D., Barbu A., Mehmeti I., Vercamer C., Welsh N. Overexpression of the nuclear factor-{kappa}B subunit c-Rel protects against human islet cell death in vitro. Am. J. Physiol. Endocrinol. Metab. 2009.
43. Kwon G., Corbett J.A., Rodi C.P., Sullivan P., McDaniel M.L. Interleukin-1 beta-induced nitric oxide synthase expression by rat pancreatic beta-cells: evidence for the involvement of nuclear factor kappa B in the signaling mechanism. Endocrinology 1995, 136:4790-4795.
44. Kouzarides T. Chromatin modifications and their function. Cell 2007, 128:693-705.
45. Donath M.Y., Boni-Schnetzler M., Ellingsgaard H., Ehses J.A. Islet inflammation impairs the pancreatic beta-cell in type 2 diabetes. Physiology (Bethesda) 2009, 24:325-331.
46. Ehses J.A., Perren A., Eppler E., Ribaux P., Pospisilik J.A., Maor-Cahn R., Gueripel X., Ellingsgaard H., Schneider M.K., Biollaz G., Fontana A., Reinecke M., Homo-Delarche F., Donath M.Y. Increased number of islet-associated macrophages in type 2 diabetes. Diabetes 2007, 56:2356-2370.
47. Rydgren T., Oster E., Sandberg M., Sandler S. Administration of IL-1 trap prolongs survival of transplanted pancreatic islets to type 1 diabetic NOD mice. Cytokine 2013, 63:123-129.
48. Butcher M.J., Hallinger D., Garcia E., Machida Y., Chakrabarti S., Nadler J., Galkina E.V., Imai Y. Association of proinflammatory cytokines and islet resident leucocytes with islet dysfunction in type 2 diabetes. Diabetologia 2014, 57(3):491-501.
49. Campbell I.L., Oxbrow L., Harrison L.C. Reduction in insulitis following administration of IFN-gamma and TNF-alpha in the NOD mouse. J. Autoimmun. 1991, 4:249-262.
50. Rabinovitch A., Sumoski W., Rajotte R.V., Warnock G.L. Cytotoxic effects of cytokines on human pancreatic islet cells in monolayer culture. J. Clin. Endocrinol. Metab. 1990, 71:152-156.
51. Yamada K., Takane N., Otabe S., Inada C., Inoue M., Nonaka K. Pancreatic beta-cell-selective production of tumor necrosis factor-alpha induced by interleukin-1. Diabetes 1993, 42:1026-1031.
52. Bamborough P., Callahan J.F., Christopher J.A., Kerns J.K., Liddle J., Miller D.D., Morse M.A., Rumsey W.L., Williamson R. Progress towards the development of anti-inflammatory inhibitors of IKKbeta. Curr. Top. Med. Chem. 2009, 9:623-639.
53. Grewal I.S., Rutledge B.J., Fiorillo J.A., Gu L., Gladue R.P., Flavell R.A., Rollins B.J. Transgenic monocyte chemoattractant protein-1 (MCP-1) in pancreatic islets produces monocyte-rich insulitis without diabetes: abrogation by a second transgene expressing systemic MCP-1. J. Immunol. 1997, 159:401-408.
54. Martin A.P., Rankin S., Pitchford S., Charo I.F., Furtado G.C., Lira S.A. Increased expression of CCL2 in insulin-producing cells of transgenic mice promotes mobilization of myeloid cells from the bone marrow, marked insulitis, and diabetes. Diabetes 2008, 57:3025-3033.
55. Kriegel M.A., Rathinam C., Flavell R.A. Pancreatic islet expression of chemokine CCL2 suppresses autoimmune diabetes via tolerogenic CD11c+ CD11b+ dendritic cells. Proc. Nat. Acad. Sci. U.S.A. 2012, 109:3457-3462.
56. Mastrandrea L., Yu J., Behrens T., Buchlis J., Albini C., Fourtner S., Quattrin T. Etanercept treatment in children with new-onset type 1 diabetes: pilot randomized, placebo-controlled, double-blind study. Diabetes Care 2009, 32:1244-1249.
57. Stanley T.L., Zanni M.V., Johnsen S., Rasheed S., Makimura H., Lee H., Khor V.K., Ahima R.S., Grinspoon S.K. TNF-alpha antagonism with etanercept decreases glucose and increases the proportion of high molecular weight adiponectin in obese subjects with features of the metabolic syndrome. J. Clin. Endocrinol. Metab. 2011, 96:E146-E150.
58. Tack C.J., Kleijwegt F.S., Van Riel P.L., Roep B.O. Development of type 1 diabetes in a patient treated with anti-TNF-alpha therapy for active rheumatoid arthritis. Diabetologia 2009, 52:1442-1444.
59. Schulthess F.T., Paroni F., Sauter N.S., Shu L., Ribaux P., Haataja L., Strieter R.M., Oberholzer J., King C.C., Maedler K. CXCL10 impairs beta cell function and viability in diabetes through TLR4 signaling. Cell Metab. 2009, 9:125-139.
60. Li C.R., Mueller E.E., Bradley L.M. Islet antigen-specific Th17 cells can induce TNF-alpha-dependent autoimmune diabetes. J. Immunol. 2014, 192:1425-1432.